HBM Healthcare Investments AG EBIT

The latest EBIT for HBMN.SW is $650M as of June 2026. That compares with $-150M in the prior-year period — up 543.0% year over year. That is below the sector sector average of $2.5T. Investors often review this figure alongside HBM Healthcare Investments AG's historical trend and sector peers before judging valuation or financial health.

Over the past year, HBMN.SW's EBIT moved from $-150M to $650M — a 543.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in HBM Healthcare Investments AG's operating scale or balance-sheet position.

Against its sector companies, HBMN.SW currently prints $650M for EBIT, while the sector average sits near $2.5T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at HBM Healthcare Investments AG's growth, margins, and balance sheet.

A EBIT figure of $650M for HBMN.SW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.5T. Explore the charts below for those layers of context.

After noting HBMN.SW's EBIT ($650M), review year-over-year change from $-150M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.